Skip to content

DE LANDLOPER

Active
Private limited companyfounded 200521 years activeGrondwetplein 2, 1060 Sint-Gillis (bij-Brussel), BelgiumKBO/BCE: BE 0872.765.121
Summary

DE LANDLOPER has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €390,905 and a net result of -€17,848. Equity is growing by ~2.7% per year across the filed fiscal years. Its solvency ranks better than 61% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
1 site
Size
€531,057total assets 2025
Equity
€390,905
Loss
-€17,848
Turnover not published (abridged schema)
Financial health
92 Excellent Checked score 2025
Bankruptcy probability, 12 months
< 0.1%
Structure
Accounts 11 days early0 of 3 deeds read
Why 92+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 4.80, cash €112,482+ Size: total assets €531,057+ Equity €390,905 (73.6% of total assets)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 99+1
equity 73.6% of total assets
Liquidity 76-17
short-term debt 9.6% · cash 21.2%
Profitability 44-21
return on assets -3.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,969 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: 0.1%▲ +0.1 percentage points vs 01-2025highest value 03-2025: < 0.1%▼ -0.1 percentage points vs 02-2025lowest value 04-2025: < 0.1%● unchanged vs 03-2025lowest value 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit up to €35,000 at 30 days acceptable
Liquidity ample (current ratio 4.8 against 5.16 in 2024; short-term debt: 9.6% and cash: 21.2% of total assets), and 26.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 62% on solvency, 58% on liquidity, 7% on profitability and 30% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.80, cash €112,482
NBB · annual accounts
lowers risk · Size: total assets €531,057
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €390,905 (73.6% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€17,848
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 20-01-2026, 11 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
11 days early
2024
17 days late
2023
1 day early
2022
8 days early
2021
7 days early
2020
1 day late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 24 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close07-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Risk: 3 loss-making years in a rowloss fiscal year 2025 -€17,848 View
  • Caution: Among the weakest 5% on net resultsector median €60,298 · 20,362 companies -€17,848 View
  • Total assets 20256 fiscal years filed €531,057 View

By topic

Financials

Fiscal year
2025
Total assets
€531,057
Loss
-€17,848
Solvency
73.6%
Total assets▼ 5.4%
Net result
20192025
Go to Financials

Timeline

Events
11
Since
2017
Next accounts
by 31-01-2027
  1. 30-06-2023Weakest financial year
  2. 23-01-2023Annual accounts filed
  3. 24-01-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
25-03-2005
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.